Benchmark Upgrades Neogenomics (NEO) to Buy
Tweet
Share
E-mail
Get Alerts NEO Hot Sheet
Price: $10.14 +0.20%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Benchmark analyst Bruce Jackson upgraded Neogenomics (NASDAQ: NEO) from Hold to Buy.
For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.
Shares of Neogenomics closed at $9.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
- Some Glazer family members said to consider selling Manchester United plc (MANU) stake - Bloomberg
- RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
